Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Chemotherapy
|
January 1, 1981
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life
K Stoeckel
Brain Research
|
February 28, 1975
Retrograde axonal transport of nerve growth factor: specificity and biological importance
K Stoeckel, H Thoenen
European Journal of Clinical Pharmacology
|
January 1, 1986
Biliary excretion of ceftriaxone
W Hayton, K Stoeckel
The American Journal of Medicine
|
October 19, 1984
Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model
K Stoeckel, J R Koup
Antimicrobial Agents and Chemotherapy
|
February 1, 1982
Single-dose pharmacokinetics of ceftriaxone in infants and young children
U B Schaad, K Stoeckel
Chemotherapy
|
January 1, 1992
The pharmacokinetics of new oral cephalosporins in children
D J Edwards, K Stoeckel
Lancet (London, England)
|
August 13, 1994
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newborn
P H Joubert, K Stoeckel
Clinical Pharmacokinetics
|
September 1, 1993
Cefetamet pivoxil clinical pharmacokinetics
R A Blouin, K Stoeckel
Clinical Pharmacokinetics
|
January 1, 1986
Age-associated changes in ceftriaxone pharmacokinetics
W L Hayton, K Stoeckel
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state
K Stoeckel, M Harell, M Dan
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Chemotherapy
|
January 1, 1981
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life
K Stoeckel
Brain Research
|
February 28, 1975
Retrograde axonal transport of nerve growth factor: specificity and biological importance
K Stoeckel, H Thoenen
European Journal of Clinical Pharmacology
|
January 1, 1986
Biliary excretion of ceftriaxone
W Hayton, K Stoeckel
The American Journal of Medicine
|
October 19, 1984
Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model
K Stoeckel, J R Koup
Antimicrobial Agents and Chemotherapy
|
February 1, 1982
Single-dose pharmacokinetics of ceftriaxone in infants and young children
U B Schaad, K Stoeckel
Chemotherapy
|
January 1, 1992
The pharmacokinetics of new oral cephalosporins in children
D J Edwards, K Stoeckel
Lancet (London, England)
|
August 13, 1994
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newborn
P H Joubert, K Stoeckel
Clinical Pharmacokinetics
|
September 1, 1993
Cefetamet pivoxil clinical pharmacokinetics
R A Blouin, K Stoeckel
Clinical Pharmacokinetics
|
January 1, 1986
Age-associated changes in ceftriaxone pharmacokinetics
W L Hayton, K Stoeckel
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state
K Stoeckel, M Harell, M Dan
Page
of 7